IMPLEMENTING HEALTH CARE TRANSITION PROCESS FOR SICKLE CELL USING QUALITY IMPROVEMENT

Speaker(s)

• 

  Payal C. Desai, MD (she/her/hers)

  Director, Sickle Cell Enterprise/ Associate professor
  Levine Cancer Institute
  Levine Cancer Institute
  Charlotte, North Carolina, United States

  Slides

First Author(s)

• IO

  Ify Osunkwo, MD

  Professor
  1. The Levine Cancer Institute, Division of Hematological Oncology and Blood Disorders, Atrium Health, Charlotte NC, 6. Novo Nordisk A/S, Rare Disease Division, Zurich, Switzerland, New Jersey, United States

Author(s)

• JC

  Jennifer Cornette, MPH

  Outcomes Specialist
  Levine Cancer Institute
  Charlotte, North Carolina, United States
• PW

  Patience White, MD, MA, MACP, FAAP

  Co-Director
  Got Transition, District of Columbia, United States
• PM

  Peggy McManus, MPH

  President, Co-Diector of Got Transition
  The National Alliance of Advance Adolescent Health, District of Columbia, United States
• CC

  Cheryl Courtlandt, MD

  Professor
  Atrium Health, North Carolina, United States
• LN

  Laura Noonan, MD

  Professor
  Atrium Health, North Carolina, United States
• CP

  Charity Galena Paterson, PhD, MSPH

  Professor and Director, SRS Data Center
  UPMC, Pennsylvania, United States
• RL

  Raymona Lawrence, DrPH, MPH, CDE

  Associate Professor-Community Health Behavior and Education
  Georgia Southern University, Georgia, United States

Corresponding Author(s)

• 

  Payal C. Desai, MD (she/her/hers)

  Director, Sickle Cell Enterprise/ Associate professor
  Levine Cancer Institute
  Levine Cancer Institute
  Charlotte, North Carolina, United States

  Slides

Author(s)

• 

  Payal C. Desai, MD (she/her/hers)

  Director, Sickle Cell Enterprise/ Associate professor
  Levine Cancer Institute
  Levine Cancer Institute
  Charlotte, North Carolina, United States

  Slides